Literature DB >> 16100093

Abnormalities of vasomotor regulation in the pathogenesis of the acute charcot foot of diabetes mellitus.

William J Jeffcoate1.   

Abstract

The acute Charcot foot complicates distal symmetrical neuropathy but is remarkably rare. This article reviews the multiple processes that may complicate both diabetes and neuropathy and might, in turn, explain the association of features that are typical of this disorder: osteolysis, vascular calcification in association with intact lower limb blood flow, and uncontrolled inflammation. Specifically, it is suggested that the disorder arises because of abnormal expression of the nuclear transcription factor, NFkappaB, in diabetic neuropathy and that this is further enhanced at the onset of the acute arthropathy as a result of the release of proinflammatory cytokines, such as tumor necrosis factor-alpha and interleukin-1. These proinflammatory cytokines and RANKL may then enter a cycle of mutual augmentation, and this is a factor that underlies the continuing inflammation that characterizes the disorder. If this hypothesis is confirmed, it would suggest the option of new effective treatments for this sometimes devastating disorder.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16100093     DOI: 10.1177/1534734605280447

Source DB:  PubMed          Journal:  Int J Low Extrem Wounds        ISSN: 1534-7346            Impact factor:   2.057


  9 in total

1.  [Tibiotalocalcaneal corrective arthrodesis in Charcot arthropathy of the ankle with a retrograde nail].

Authors:  J von Recum
Journal:  Oper Orthop Traumatol       Date:  2015-04-10       Impact factor: 1.154

Review 2.  Age-associated chronic diseases require age-old medicine: role of chronic inflammation.

Authors:  Sahdeo Prasad; Bokyung Sung; Bharat B Aggarwal
Journal:  Prev Med       Date:  2011-12-09       Impact factor: 4.018

3.  SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy.

Authors:  Andrea M Vincent; James W Russell; Kelli A Sullivan; Carey Backus; John M Hayes; Lisa L McLean; Eva L Feldman
Journal:  Exp Neurol       Date:  2007-08-03       Impact factor: 5.330

Review 4.  [Charcot foot. Current situation and outlook].

Authors:  T Mittlmeier; K Klaue; P Haar; M Beck
Journal:  Unfallchirurg       Date:  2008-04       Impact factor: 1.000

Review 5.  Neuropathic osteoarthropathy with and without superimposed osteomyelitis in patients with a diabetic foot.

Authors:  Antonio Leone; Victor N Cassar-Pullicino; Alessia Semprini; Laura Tonetti; Nicola Magarelli; Cesare Colosimo
Journal:  Skeletal Radiol       Date:  2016-02-17       Impact factor: 2.199

6.  A prospective study of calcaneal bone mineral density in acute Charcot osteoarthropathy.

Authors:  Nina L Petrova; Michael E Edmonds
Journal:  Diabetes Care       Date:  2010-07-13       Impact factor: 19.112

7.  IL-17 cytokines in bone healing of diabetic Charcot arthropathy patients: a prospective 2 year follow-up study.

Authors:  Agnetha Folestad; Martin Ålund; Susanne Asteberg; Jesper Fowelin; Ylva Aurell; Jan Göthlin; Jean Cassuto
Journal:  J Foot Ankle Res       Date:  2015-08-18       Impact factor: 2.303

8.  An overview of the Charcot foot pathophysiology.

Authors:  Gökhan Kaynak; Olgar Birsel; Mehmet Fatih Güven; Tahir Oğüt
Journal:  Diabet Foot Ankle       Date:  2013-08-02

9.  Abnormally Large Synovial Herniation Resulting in Progressive Rocker Bottom Deformity in a Patient with Idiopathic Midfoot Charcot Neuroarthropathy: A Case Report.

Authors:  Craig Verdin; Nilin M Rao
Journal:  Cureus       Date:  2019-12-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.